The ShcA protein is a molecular chaperone that assists in the secretion of the HopPsyA effector from the type III (Hrp) protein secretion system of Pseudomonas syringae ShcA represents the first demonstrated chaperone used in a type III secretion system of a bacterial plant pathogen. We searched known P. syringae type III-related genes for neighbouring ORFs that shared the general characteristics of type III chaperones and identified five additional candidate type III chaperones. Therefore, it is likely that chaperones are as prevalent in bacterial plant pathogen type III systems as they are in their animal pathogenic counterparts.
Introduction
Type III protein secretion systems are present in many Gram-negative pathogens of both plants and animals (Hueck, 1998; Galán and Collmer, 1999; Cornelis and van Gijsegem, 2000) . These secretion systems are particularly noteworthy because they can translocate effector proteins directly into eukaryotic cells (Cornelis and Wolf-Watz, 1997) . In bacterial plant pathogens belonging to the genera Erwinia, Pseudomonas, Ralstonia and Xanthomonas, type III systems (also referred to as Hrp systems) are encoded by hrp/hrc genes (Lindgren, 1997; He, 1998) . Hrp systems were originally discovered because phytopathogens require them for elicitation of the hypersensitive response (HR) on non-host plants and pathogenesis on host plants . The HR is a programmed cell death of plant cells associated with plant defence (Klement, 1982) . The effectors secreted by Hrp systems have been referred to as Hop proteins (for Hrp-dependent outer protein) . A subset of the Hops was identified because they were recognized by the resistance (R) gene-based surveillance systems of plants and have historically been referred to as avirulence (Avr) proteins. Indirect evidence supports the view that at least a subset of Avr proteins are translocated into plant cells by the type III system, where they initiate an HR Kjemtrup et al., 2000) . Recently, several Avr proteins have been shown to be secreted in culture by the type III secretion systems of plant pathogens (Ham et al., 1998; van Dijk et al., 1999; Mudgett and Staskawicz, 1999; Rossier et al., 1999) .
Pseudomonas syringae pathovars cause diseases on many different agricultural crops, which produce a wide
Summary
Pseudomonas syringae uses a type III protein secretion system encoded by the Hrp pathogenicity island (Pai) to translocate effector proteins into plant cells. One of these effector proteins is HopPsyA. A small open reading frame (ORF), named shcA, precedes the hopPsyA gene in the Hrp Pai of P. s. syringae 61. The predicted amino acid sequence of shcA shares general characteristics with chaperones used in type III protein secretion systems of animal pathogens. A functionally non-polar deletion of shcA in P. s. syringae 61 resulted in the loss of detectable HopPsyA in supernatant fractions, consistent with ShcA acting as a chaperone for HopPsyA. Cosmid pHIR11 carries a functional set of type III genes from P. s. syringae 61 and confers upon saprophytes the ability to secrete HopPsyA in culture and to elicit a HopPsyA-dependent hypersensitive response (HR) on tobacco. P. fluorescens carrying a pHIR11 derivative lacking shcA failed to secrete HopPsyA in culture, but maintained the ability to secrete another type III-secreted protein, HrpZ. This pHIR11 derivative was also greatly reduced in its ability to elicit an HR, indicating that the ability to translocate HopPsyA into plant cells was compromised. Using affinity chromatography, we showed that ShcA binds directly to HopPsyA and that the ShcA binding site must reside within the first 166 amino acids of HopPsyA. Thus, variety of symptoms including foliar spots, specks and blights. P. syringae interactions with plants are specific: certain pathovars can only infect certain plant species. Much of the specificity seen in these interactions results from the presence of avr genes and the gene-for-gene interactions that they have with plant R genes (Keen, 1990; Dangl, 1994) . Relatively recently, the pathogenicity island (Pai) that encodes the Hrp system of P. syringae strains has been reported (Alfano et al., 2000) . The Hrp Pai has a tripartite structure: the centre of it carries the conserved hrp/hrc gene cluster that encodes the main components of the secretion apparatus; one flank contains another conserved region termed the conserved effector locus (CEL) because it encodes several secreted products; and the other flank carries a variable region designated the exchangeable effector locus (EEL) because it is dissimilar even between closely related strains of P. syringae and appears to carry hop genes and avr genes.
The EEL of P. s. syringae 61 carries only two discernible open reading frames (ORFs): ORF1 and hopPsyA (formerly known as hrmA) (Heu and Hutcheson, 1993; . The HopPsyA protein is secreted in culture by P. syringae and, when expressed transiently in tobacco, it elicits an HR, indicating that its site of action is inside plant cells van Dijk et al., 1999; Collmer et al., 2000) . The predicted product of ORF1 shares several of the general characteristics of chaperones used in the type III systems of animal pathogens (Wattiau et al., 1996; Cornelis et al., 1998) .
Type III chaperones have been identified in several animal pathogens (Ménard et al., 1994; Day and Plano, 1998; Fu and Galán, 1998; Wainwright and Kaper, 1998; Page et al., 2001) and, other than between homologues, they share little amino acid sequence similarity with each other. However, they do share several general structural characteristics such as a small size, an acidic isoelectric point and predicted a-helical secondary structure (Wattiau et al., 1996; Bennett and Hughes, 2000; Plano et al., 2001) . Chaperones have been shown to prevent premature aggregation of effectors in the bacterial cytoplasm and/or to prevent cytoplasmic proteolysis of effectors (Ménard et al., 1994; Wattiau et al., 1994) . One of the better defined chaperone/effector pairs is SycE/YopE from Yersinia spp. (Wattiau and Cornelis, 1993) . SycE has been shown to bind directly to amino acids 15-50 of the YopE effector (Schesser et al., 1996; Woestyn et al., 1996) , stabilizing YopE in the bacterial cytoplasm (FrithzLindsten et al., 1995; Cheng et al., 1997) and apparently giving YopE a competitive advantage over other effectors for access to the type III apparatus (Boyd et al., 2000) . The recent determination of the crystal structure of the Salmonella SicP/SptP chaperone/effector pair indicates that the SptP effector is partially unfolded when the SicP chaperone is bound to it, which may indicate that SicP helps to maintain SptP in a secretion-competent state (Stebbins and Galán, 2001) .
To date, the presence of type III chaperones in plant pathogens has not been demonstrated, and a recent review noted that the presence of customized chaperones in animal pathogen type III systems may illustrate a substantial difference between animal and plant pathogen type III systems (Staskawicz et al., 2001) . However, it has been reported that ORF1 upstream of hopPsyA and DspB resemble type III chaperones (Gaudriault et al., 1997) . Moreover, DspB is required for the type III secretion of DspA from Erwinia amylovora (Gaudriault et al., 1997) , consistent with DspB acting as a type III chaperone. We describe here the identification and characterization of ShcA and demonstrate that it is a type III chaperone for the P. syringae effector HopPsyA.
Results

ORF1 has chaperone-like characteristics
The predicted amino acid sequence of the ORF preceding hopPsyA, ORF1, in the EEL of P. s. syringae 61 shares general characteristics with chaperones used in Leu and queA genes depicted as grey boxes. A 5¢-truncated hrpK gene is represented as a hatched box. The arrows indicate the predicted direction of transcription, and the black box denotes the presence of a putative HrpL-dependent promoter upstream of the shcA ORF. B. Construction of the deletion mutation in the shcA ORF marker exchanged into P. s. syringae 61. Black bars depict regions that were amplified along with added restriction enzyme sites, and each is aligned with the corresponding DNA region represented in (A). The striped box depicts the nptII cassette that lacks transcriptional and translational terminators used in making the functionally nonpolar shcA P. s. syringae 61 mutant. EcoRI, E; EcoRV, V; XbaI, X; and XhoI, Xh.
type III protein secretion systems of animal pathogens (Wattiau et al., 1996) . The predicted product of ORF1 is relatively small (12.6 kDa), has an acidic pI (4.8) and a predicted amphipathic region in its C-terminal region, all characteristics consistent with it encoding a type III chaperone. The proximity of ORF1 to hopPsyA and the presence of a Hrp promoter immediately upstream of both hopPsyA and ORF1 indicates that they are probably part of the same transcriptional unit. The organization of the predicted operon containing ORF1 and hopPsyA is shown in Fig. 1A . To test whether ORF1 encodes a protein product, two ORF1-FLAG constructs were made, pLN84 and pLN100. Translation of ORF1 carried on pLN84 was dependent on a vector ribosome binding site (RBS), and translation of ORF1 carried on pLN100 was dependent on the native RBS upstream of ORF1 in the P. s. syringae 61 chromosome. Escherichia coli strains expressing either construct produced an ORF1-FLAG protein detected by anti-FLAG antibodies, indicating that the native RBS was functional and that ORF1 does encode a protein (data not shown). The product of ORF1 will hereafter be referred to as ShcA (for specific Hop chaperone).
A P. s. syringae 61 shcA mutant fails to secrete the HopPsyA effector Because ShcA shares general similarities with type III chaperones, we tested whether a loss-of-function mutation in shcA would alter the stability and the type III secretion of HopPsyA. A functionally non-polar deletion mutation was constructed in the shcA coding region and transferred to the chromosome of P. s. syringae 61 (see Fig. 1B and Experimental procedures). The resulting mutant was designated UNL131. P. s. syringae 61 cultures were grown in Hrp-inducing fructose medium at 22∞C and separated into cell-bound and supernatant fractions. HopPsyA was found in the supernatant fraction of the wild-type P. s. syringae 61 as reported previously (van Dijk et al., 1999) , but could not be detected in the supernatant fraction from the shcA mutant, UNL131, consistent with ShcA acting as a HopPsyA chaperone (Fig. 2) . The mutation carried by UNL131 is non-polar, as demonstrated by the presence of HopPsyA in the cell-bound fraction of UNL131. The ability of UNL131 to secrete HopPsyA was restored by supplying shcA in trans on pLN106 (Fig. 2) . The secretion of HopPsyA by UNL131 was also complemented by pLN92, which carries both shcA and hopPsyA, and pLN1, which only carries hopPsyA. Thus, whatever the role of ShcA, the production of more HopPsyA inside the bacterial cell can apparently compensate for ShcA's absence. However, when shcA and hopPsyA are both supplied in trans on construct pLN92, more HopPsyA is detected in the supernatant fraction than when hopPsyA is supplied alone (Fig. 2) . There are several examples of mutations in genes predicted to encode type III chaperones that dramatically affect the stability of their cognate effector (Wattiau and Cornelis, 1993; Fu and Galán, 1998; Niebuhr et al., 2000) . However, the P. s. syringae shcA mutant UNL131 did not dramatically alter the stability of HopPsyA based on the presence of HopPsyA in the cell-bound fraction of © 2002 Blackwell Science Ltd, Molecular Microbiology, 44, 1469-1481 Fig. 2 . A P. s. syringae 61 shcA mutant UNL131 does not secrete HopPsyA, and shcA provided in trans complements this defect. P. s. syringae 61 cultures were grown at 22∞C in hrp-inducing medium and separated into cell-bound (C) and supernatant fractions (S). The cell-bound fractions were concentrated 13.3-fold, and the supernatant fractions were concentrated 100-fold relative to the initial culture volumes. The samples were subjected to SDS-PAGE and immunoblot analysis, and HopPsyA and b-lactamase (Bla) were detected with either anti-HopPsyA or anti-b-lactamase antibodies followed by secondary antibodies conjugated to alkaline phosphatase as described in Experimental procedures. The image of the immunoblot was captured using a HewlettPackard 6200C ScanJet scanner with the accompanying software. For figure construction, the image was manipulated with Microsoft POWERPOINT 2000 to meet the publisher's specifications. 61, wild type; 61-2089, type III secretion mutant; UNL131, shcA mutant; pLN106, construct carrying shcA; pLN92, construct carrying shcA and hopPsyA; pLN1, construct carrying hopPsyA. All the bacterial strains carried pCPP2318, which encodes the mature b-lactamase. UNL131 (Fig. 2) . Moreover, pulse-chase experiments comparing HopPsyA stability in the shcA mutant UNL131 and wild-type P. s. syringae 61 were unable to detect any decrease in HopPsyA stability in the absence of ShcA (data not shown).
A functional type III secretion system encoded by cosmid pHIR11 requires ShcA for HopPsyA secretion but not for the type III secretion of HrpZ
Cosmid pHIR11 carries a functional set of type III genes from P. s. syringae 61 and shcA and hopPsyA, which collectively confer upon non-plant pathogens such as P. fluorescens the ability to secrete HopPsyA in culture and to elicit an HR on tobacco (van Dijk et al., 1999; Collmer et al., 2000) . To investigate ShcA's role in HopPsyA secretion further, we marker exchanged a non-polar shcA mutation into pHIR11 constructing pLN85. P. fluorescens cultures grown in Hrp-inducing conditions were separated into cell-bound and supernatant fractions. P. fluorescens(pLN85) was unable to secrete detectable amounts of HopPsyA into the supernatant fraction, indicating that, like the P. s. syringae shcA mutant, bacteria carrying a pHIR11 derivative lacking shcA were unable to secrete HopPsyA in culture (Fig. 3) . P. fluorescens(pLN85) also carrying pLN105, which contains shcA, regained the ability to secrete HopPsyA to the supernatant fraction. Interestingly, the type III secretion defect possessed by P. fluorescens(pLN85) was not a general defect in type III secretion because this strain was still capable of secreting HrpZ, another protein that travels the type III pathway (Fig. 3) . Moreover, P. fluorescens(pLN85) was capable of secreting the Avr protein AvrPto in culture, further supporting the view that the shcA mutation specifically affected HopPsyA secretion (data not shown).
ShcA affects the translocation of HopPsyA into plant cells
Bacteria carrying pHIR11 require hopPsyA for HR elicitation on tobacco, and HopPsyA expressed transiently in tobacco cells is sufficient to elicit an HR, indicating that HopPsyA is translocated to the interior of tobacco cells where it is recognized by the plants defence system, resulting in the triggering of defences including the HR 1997; Collmer et al., 2000) . To determine whether shcA was required for the translocation of HopPsyA inside plant cells, we tested the ability of P. fluorescens(pLN85) to elicit a HopPsyA-dependent HR on tobacco (Nicotiana tabacum cv. Xanthi). P. fluorescens(pLN85) was often completely unable to elicit an HR, producing a similar response to bacteria carrying pHIR11 derivatives that encode disabled type III secretion systems. This suggests that ShcA is required for the translocation of HopPsyA into plant cells. However, occasionally, a greatly reduced HR was visible on tobacco that was infiltrated with P. fluorescens(pLN85), indicating that ShcA dramatically affected the translocation of HopPsyA into plant cells, but apparently some HopPsyA can still be translocated into plant cells from bacterial cells lacking ShcA (Fig. 4) . The reduced HR phenotype produced by P. fluorescens(pLN85) was complemented when shcA was supplied in trans (Fig. 4) . The fact that we were unable to detect any HopPsyA in supernatant fractions in type III secretion assays using strains lacking ShcA (Figs 2 and 3), but were able variably to detect a weak HopPsyA-dependent HR in plant experi- Fig. 3 . shcA is required for the type III secretion of HopPsyA, but not HrpZ secretion. P. fluorescens 55 cultures were grown in hrpinducing medium and separated into cellbound (C) and supernatant (S) fractions. The cell-bound fractions were concentrated 13.4-fold, and the supernatant fractions were concentrated 133-fold relative to the initial culture volumes. The samples were subjected to SDS-PAGE and immunoblot analysis, and HopPsyA and HrpZ were detected with either anti-HopPsyA or anti-HrpZ antibodies followed by secondary antibodies conjugated to alkaline phosphatase as described in Experimental procedures. The image of the immunoblot was captured using a Hewlett-Packard 6200C ScanJet scanner with the accompanying software. For figure construction, the image was manipulated with Microsoft POWERPOINT 2000 to meet the publisher's specifications. pHIR11, wild-type Hrp system; pCPP2089, encodes a defective Hrp system; pLN85, pHIR11 derivative with shcA mutation; pLN105, broad-host-range plasmid carrying shcA. ments, indicates that the translocation assay appears to be more sensitive than our secretion assays in detecting HopPsyA.
ShcA interacts with HopPsyA
One criterion that any protein suspected of being a chaperone must fulfil is that it must bind to the protein that it is predicted to chaperone. To determine whether ShcA binds to HopPsyA in vitro, we made constructs using polymerase chain reaction (PCR) that contained either hopPsyA alone (pLN1) or both hopPsyA and shcA-flag (pLN2). These plasmids were electroporated into the P. s. syringae shcA mutant UNL131, and strains containing both constructs were grown separately in King's B broth medium to an optical density of 1.0 (see Experimental procedures). The cells were sonicated, and the soluble proteins were incubated with anti-FLAG affinity gel that binds to the FLAG epitope. The sonicate, wash and gel fractions were separated on SDS-PAGE gels and analysed with immunoblots using antibodies that recognize either HopPsyA or ShcA-FLAG. HopPsyA was only detected in the gel fraction in the presence of ShcA-FLAG, indicating that HopPsyA binds to ShcA, which is consistent with ShcA acting as a molecular chaperone for HopPsyA (Fig. 5) . It is important to note that the wash fractions presented in Fig. 5 represent the last wash of the gel samples before eluting bound proteins from the gel. Thus, the gels were washed sufficiently such that the detected HopPsyA was interacting specifically with ShcA-FLAG bound to the anti-FLAG affinity gel. The absence of HopPsyA in the gel fraction from the sample that lacked ShcA-FLAG further supports the fact that HopPsyA was binding specifically to ShcA-FLAG (Fig. 5 ).
ShcA interacts with the N-terminal 166 amino acids of HopPsyA
To determine what portion of HopPsyA interacts with ShcA, we carried out similar experiments to those described above (Fig. 5) . We PCR cloned fragments of hopPsyA that corresponded to the N-terminal 166 amino acids, C-terminal 276 amino acids and the C-terminal 256 amino acids of HopPsyA into a pML123 derivative containing shcA-flag, constructing pLN67, pLN68 and pLN69 respectively. These constructs were electroporated into the P. s. syringae 61 shcA mutant UNL131 and grown as described above. Soluble protein samples were isolated from sonicated cultures and mixed with anti-FLAG affinity gel. After several washes, the gel fractions were loaded onto SDS-PAGE gels and analysed with immunoblots with antibodies that recognized either HopPsyA or ShcA-FLAG. Only the cultures carrying pLN67 produced a © 2002 Blackwell Science Ltd, Molecular Microbiology, 44, 1469-1481 Fig. 4 . Tobacco leaves showing that P. fluorescens 55 carrying a pHIR11 derivative with a functionally non-polar shcA mutation is impaired in its ability to translocate HopPsyA into plant cells. P. fluorescens 55 cultures were grown overnight in King's Broth, suspended in 5 mM MES, pH 5.6, to an OD 600 of 1.0 and infiltrated into tobacco leaf panels. Because the pHIR11-induced HR results from the translocation of HopPsyA inside plant cells, a reduced HR indicates that HopPsyA is not delivered well enough to induce a confluent HR. The leaf panels were photographed with incident light 24 h later. pHIR11, HR + wild-type Hrp system; pCPP2089, HR -defective Hrp system; pLN85, pHIR11 derivative with shcA mutation; pLN105, broad-host-range plasmid carrying shcA.
Fig. 5.
Immunoblot showing that ShcA binds to HopPsyA. Soluble protein samples from sonicated cultures of P. s. syringae 61 shcA mutant UNL131 carrying pLN1 (HopPsyA) or pLN2 (ShcA-FLAG, HopPsyA) were mixed with anti-FLAG M2 affinity gel. The gel was washed with TBS buffer, mixed with SDS-PAGE buffer and, along with the sonicate and wash samples, subjected to SDS-PAGE and immunoblot analysis. HopPsyA and ShcA-FLAG were detected with anti-HopPsyA or anti-FLAG antibodies followed by secondary antibodies conjugated to alkaline phosphatase as described in Experimental procedures. The immunoblot image was scanned in to generate a digital image and imported into Microsoft POWERPOINT 2000 to construct the figure.
HopPsyA fragment that interacted with ShcA-FLAG, indicating that the ShcA binding site of HopPsyA resides in the N-terminal 166 amino acids (Fig. 6) . The constructs pLN68 and pLN69 produced the C-terminal 276 and 256 amino acids of the 376-amino-acid HopPsyA protein respectively. Because both these truncated proteins failed to bind in detectable amounts to the ShcA-FLAG-containing affinity gel, the ShcA binding site probably resides within the first 100 amino acids of HopPsyA (Fig. 6) .
Other putative type III chaperones associated with characterized type III-related P. syringae genes To investigate the prevalence of chaperones in P. syringae type III systems, we searched nucleotide sequences adjacent to known avr genes and type III-related genes for neighbouring ORFs whose predicted products share the general characteristics of type III chaperones. We limited our search to nucleotide sequences from any published P. syringae avr gene and genes within the P. syringae Hrp pathogenicity island likely to encode effectors (Alfano et al., 2000) . DNA sequences for all the deposited avr and hrp-related sequences of P. syringae were retrieved from GenBank and analysed with DNASTAR software for ORFs adjacent to putative effector genes, a common characteristic of type III chaperone genes. In some cases, there was not enough adjacent DNA to search effectively for ORFs. However, we were able to identify five ORFs neighbouring different avr or putative effector genes that represent good candidate chaperone genes. These candidate chaperone/effector pairs are listed in Table 1 along with salient features of the predicted chaperones. Therefore, it is likely that other type III chaperones exist in P. syringae and that plant pathogenic type III systems are similarly reliant on chaperones for the secretion of specific effectors as their animal pathogenic counterparts.
Discussion
Here, we report the characterization of the shcA gene of P. s. syringae 61 and its involvement in the secretion of the HopPsyA effector from the P. s. syringae type III Fig. 6 . Immunoblot showing that ShcA binds within the N-terminal 166 amino acids of HopPsyA. Soluble protein samples from sonicated cultures of UNL131 carrying pLN67, pLN68 and pLN69 were mixed with anti-FLAG M2 affinity gel. The gel was washed with TBS buffer, mixed with SDS-PAGE buffer and subjected to SDS-PAGE and immunoblot analysis. Proteins not binding to the gel were represented in a flowthrough fraction. pLN67, pLN68 and pLN69 contain shcA-flag and fragments of hopPsyA, which correspond to the N-terminal 166 amino acids (pLN67), the C-terminal 276 amino acids (pLN68) or the C-terminal 256 amino acids (pLN69) of the 376-amino-acid HopPsyA protein. HopPsyA and ShcA-FLAG were detected with anti-HopPsyA or anti-FLAG antibodies followed by secondary antibodies conjugated to alkaline phosphatase as described in Experimental procedures. The immunoblot image was scanned in to generate a digital image and imported into Microsoft POWERPOINT 2000 to construct the figure. Type III chaperones often increase the stability of the effector that they interact with (Wattiau and Cornelis, 1993; Fu and Galán, 1998; Iriarte and Cornelis, 1998) , but there are several examples where effector stability is not affected by the chaperone (Ménard et al., 1994; Woestyn et al., 1996) . Based on our findings, ShcA does not affect the stability of HopPsyA (Fig. 2) . The significance of why some effectors need chaperones to maintain their stability is presently not understood. It is possible that the chaperones that stabilize their cognate effector perform a different role in the bacterial cell than chaperones that do not.
One model that may explain why certain effectors need chaperones for their secretion, while others do not, is that a chaperone may help its cognate effector to compete against other type III traffic for entry into the type III pathway (Boyd et al., 2000) . Our result showing that overexpression of HopPsyA compensates for the absence of ShcA in secretion assays by restoring HopPsyA secretion is consistent with such a model because additional HopPsyA molecules would increase the likelihood that a fraction of the HopPsyA pool would assume a secretioncompetent state in the absence of its chaperone. Also consistent with this model is the finding that less HopPsyA remains in the cell fraction in secretion experiments using P. fluorescens carrying pHIR11 than when P. s. syringae strains are tested (van Dijk et al., 1999) . The former encodes the effectors HopPsyA and HrpK (K. van Dijk and J. R. Alfano, unpublished) , whereas the latter carries the full suite of effectors present in that strain of P. syringae.
Our search for type III chaperone-like genes adjacent to known avr or candidate effector genes in P. syringae identified five ORFs in P. syringae that may encode type III chaperones (Table 1 ). There are several additional points worth noting that increase the likelihood that these candidate chaperone genes encode bona fide chaperones. First, the EEL ORF6 present in P. s. syringae B728a is upstream of EEL ORF5, which is a homologue of AvrBsT and YopJ/P (Hardt and Galán, 1997; Ciesiolka et al., 1999) . Although this does not mandate that EEL ORF6 encodes a chaperone, the predicted product of EEL ORF6 does contain a leucine-rich repeat similar to the type found in SycE and SycH, the chaperones for the Yersinia spp. effectors YopE and YopH respectively . Moreover, adjacent to an AvrBsT homologue in E. amylovora (NCBI accession no. AAF63399) is an ORF that shares high sequence identity (55.4%) with EEL ORF6. Interestingly, chaperones have not been implicated in the secretion of AvrBsT or other YopJ/P homologues (Ciesiolka et al., 1999; Cornelis and Van Gijsegem, 2000) . Secondly, the predicted product of CEL ORF2 shares amino acid sequence identity (42.1%) with DspB/F, a protein required for the type III secretion of DspA/E, an AvrE homologue present in E. amylovora (Gaudriault et al., 1997) . Thirdly, CEL ORF4 and ORF8 are both adjacent to genes that encode proteins predicted to be type III effectors, and CEL ORF3 was recently shown to be a type III-secreted protein (A. Collmer, personal communication) . Lastly, the AvrPphF Avr activity from P. s. phaseolicola has been shown to be dependent on two adjacent ORFs, designated ORF1 and ORF2 (Tsiamis et al., 2000) . Because ORF1's predicted product shares several of the characteristics associated with chaperones, it is likely that ORF1 encodes a chaperone, thus making ORF2 a better candidate for the AvrPphF effector. It is important to note that our chaperone search was limited by the fact that many avr gene nucleotide sequences present in the databases do not contain enough adjacent sequence to determine whether a chaperone gene was located nearby. Nevertheless, we did identify candidate chaperone genes. Thus, it is likely that chaperones are as common in bacterial plant pathogen type III systems as they are in animal pathogens.
We feel that identifying P. syringae chaperone/effector pairs will be important in dissecting the molecular basis of plant pathogenesis mediated by type III secretion. Recent research on other type III secretion systems suggests that there exists a hierarchy for effector secretion. For example, the flagellar biogenesis system clearly shows that proteins are secreted in a temporal manner from this archetypal type III system for proper assembly of flagel-lar substructures, and type III chaperones appear important for this process (Fraser et al., 1999; Minamino and Macnab, 1999) . Moreover, Yersinia researchers have provided evidence suggesting that effectors required early in pathogenesis may require chaperones to compete for access to the type III secretion apparatus against effectors that are used later (Boyd et al., 2000; Lloyd et al., 2001) . If this hypothesis proves correct, then identifying chaperone/effector pairs in P. syringae may help to identify a subgroup of effectors that is used early during plant pathogenesis. Alternatively, the need for a chaperone may reflect the instability of a specific effector or the tendency of effectors to aggregate in the absence of their chaperones. With the ongoing genome sequencing project on P. s. tomato DC3000 nearing completion, continuing to search for ORFs that share general characteristics with chaperones may help in the identification of as yet unidentified effector genes in the genome of P. s. tomato DC3000.
We are continuing our characterization of the ShcA chaperone by delineating the ShcA binding site on HopPsyA more specifically, determining whether ShcA has a regulatory role as noted recently for Salmonella and Yersinia type III chaperones (Darwin and Miller, 2000; Tucker and Galán, 2000; Francis et al., 2001 ) and integrating the chaperone-binding domain of HopPsyA with other secretion signals required for HopPsyA secretion. Our long-term goal is to understand the secretion signals that successfully target HopPsyA to the type III secretion system and to determine how the ShcA chaperone facilitates this process.
Experimental procedures
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids are listed in Table 2 . E. coli strains were grown routinely in LM (Hanahan, 1983) or Terrific broth (Sambrook et al., 1989) at 37∞C. P. s. syringae 61 and P. fluorescens 55 were grown routinely in King's B broth at 30∞C (King et al., 1954) . For type III secretion assays, P. fluorescens 55 and P. s. syringae 61 were grown in Hrp-inducing fructose minimal medium described by Huynh et al. (1989) at 22∞C. Antibiotics were used at the following concentrations (mg ml -1 ): ampicillin, 100; gentamicin, 10; kanamycin, 50; spectinomycin, 50; and tetracycline, 20.
Plant materials and HR assay
Tobacco plants (Nicotiana tabacum L. cv. Xanthi) were grown in a greenhouse with a photoperiod of 16 h. Infiltration of tobacco leaves with P. fluorescens carrying pHIR11 derivatives was done by resuspending cultures grown on King's B plates in 5 mM MES (pH 5.6) at an OD 600 of 1.0 and infiltration into leaf punctures with needleless syringes. HRs were evaluated after 24 h.
General DNA manipulations and plasmid constructions
Restriction enzymes, T4 ligase and DNA polymerase were purchased from either New England Biolabs or Life Technologies. The thermostable DNA polymerase used in PCRs was Pfu polymerase (Stratagene). The cycling parameters used for PCRs were: 1 min at 94∞C; 30 cycles of 45 s at 94∞C, 45 s at 55∞C and 3 min at 72∞C; and 10 min at 72∞C. Standard molecular biological techniques were used according to well-described protocols (Sambrook et al., 1989) .
The plasmid constructs that produce ShcA fused to the FLAG epitope were made in the following way. shcA was PCR amplified from pHIR11 using the primers 5¢-ATGAAA GCTTCCCGCCTTGGCGTTTGAC-3¢ and 5¢-ATGAAGATCT CGTGCGGGCTTCTCGCCA-3¢, which have HindIII and BglII restriction sites, respectively, and subcloned into the HindIII and BglII sites of pFLAG-CTC resulting in pLN84. The construct that contains the native shcA ribosome binding site (RBS), pLN100, was made by PCR amplifying shcA from pHIR11 with 5¢-ATGAAAGCTTGGCGAACCGATTATGAGT-3¢, which anneals upstream of the shcA RBS and contains a HindIII site, and 5¢-CGCCTCTAGATTATTTGTATAGTTCATC CATGCCATG-3¢, which contains the eight codons that encode the FLAG epitope and a XhoI site, and cloning it into the corresponding sites in pBluescript-II SK+. For complementation experiments that needed the native shcA gene, the shcA coding region along with its RBS was PCR amplified with 5¢-ATGAAAGCTTGGCGAACCGATTATGAGT-3¢, which contains a HindIII site, and 5¢-ATGACCCGGGTCACGTG CGGGCTTCTCG-3¢, which contains a SmaI site, and subcloned into two different broad-host-range vectors, pBBR1MCS-5 and pMB393, resulting in pLN105 and pLN106 respectively. pLN1 was made by PCR amplifying hopPsyA with the primers 5¢-ATATAAGCTTAGGAGCTTTTAATGAACCCT-3¢, which contains the RBS of hopPsyA and a HindIII site, and 5¢-CGCCTCTAGATTATTTGTATAGTTCATCCATGCCATG-3¢, which contains an XbaI site, and subcloning the product into the corresponding sites in pML123. The shcA-FLAG DNA fragment from pLN100 was isolated by cutting with XhoI, filling in the 3¢ recessed end and cutting with BamHI. This fragment was cloned into pLN1 and pML123, both of which were previously digested with HindIII, filled in and digested with BamHI resulting in constructs pLN2 and pLN3 respectively. Plasmids pLN67, pLN68 and pLN69, which contain shcA-flag and a truncated hopPsyA fragment, were made by cloning the appropriate amplified PCR product into pLN3 that was digested with XbaI and SacI. pLN67 was made by PCR amplifying the 5¢ 498 nucleotides of hopPsyA with 5¢-CGTGTCTAGAAGGAGCTTTTAATGAACC-3¢, which contains a XbaI site and RBS, and 5¢-ATTGGAGCTCTCATCTG CCGCATTCATAGGC-3¢, which contains a SacI site and a stop codon; pLN68 was made by PCR amplifying nucleotides 300-1128 of hopPsyA with 5¢-GCTGTCTAGAAGGAGCTTTT AATGGATCTGGAGAAGGGCGGA-3¢, which contains an XbaI site, an RBS and a start codon, and 5¢-ATATG AGCTCTCAGTTTCGCGCCCTGAG-3¢, which contains a SacI site; and pLN69 was made using the PCR primers 5¢-GCTGTCTAGAAGGAGCTTTTAATGACATCAAAACAGAC ATTT-3¢, which contains an XbaI site, an RBS and a start codon, and the same reverse primer as used for construct pLN68. Ruvkin and Ausubel (1981) Construction of a deletion mutation in shcA and marker exchange into P. s. syringae 61
A schematic diagram of the P. s. syringae 61 shcA mutation construction is shown in Fig. 1B . To isolate a PCR product upstream of shcA, we relied on the sequence of the queA gene available in another strain of P. s. syringae, B728a, and designed the primer 5¢-ATGATCTAGATAGCCGTGCTC GATGGCC-3¢. Using this primer, which contains an engineered XbaI site along with a primer complementary to the region near the start of shcA, 5¢-ATGAGATATCGTC AAACGCCAAGGCGGG-3¢, which contains an EcoRV site, a 1.5 kb fragment representing the DNA upstream of the shcA gene was cloned into pCPP2988 upstream of a terminatorless nptII cassette resulting in pLN107. The 1.5 kb region immediately downstream of the shcA gene was PCR amplified from pHIR11 using the primers 5¢-ATGACTCGAGT CAATCTTCCGACGTATT-3¢ and 5¢-ATGAGGTACCTCATATT GATTGCTCCTG-3¢, which contain the restriction sites XhoI and KpnI respectively. This product was subcloned into pLN107 using XhoI and KpnI constructing pLN108. The DNA insert of pLN108 was subcloned into the XbaI and KpnI sites of the broad-host-range plasmid pRK415 constructing pLN110. This construct was electroporated into P. s. syringae 61 and plated on King's B plates containing kanamycin and tetracycline. Loss of the plasmid and retention of the nptII marker was achieved by growing P. s. syringae 61(pLN110) under Km R selection. Fresh cultures were inoculated daily with a small aliquot of the culture over a 3 day period. The last culture grown was plated on King's B plates containing kanamycin, and isolated colonies were picked onto King's B plates containing kanamycin with or without tetracycline. Total DNA was made from Km R Tc S colonies, and the P. s. syringae 61 shcA mutant, UNL131, was identified with PCR using primers that flanked the deletion site.
Construction of deletion mutation in shcA and recombination into pHIR11
To construct pLN85, a pHIR11 derivative that lacks the shcA gene, a 5 kb BglII-BamHI fragment was isolated from pHIR11 and subcloned into pBluescript-II SK+, resulting in pLN82. pLN82 carries vector sequences, shcA, hopPsyA and downstream DNA and was used as the template DNA in a PCR using the primers 5¢-GGAAACAGCTATGACCATG-3¢ and 5¢-ATGAGAATTCGCATCTCCATGCATCTT-3¢. The isolated 1.5 kb PCR product representing the DNA upstream of shcA on pHIR11 was subcloned upstream of a terminatorless nptII cassette in pCPP2988 using XbaI and EcoRI restriction enzyme sites constructing pLN83. The 1.5 kb region immediately downstream of the shcA gene was PCR amplified using the same primer set used to PCR amplify the 1.5 kb fragment downstream of shcA used in making the P. s. syringae 61 shcA mutant described above. This product was subcloned into pLN83 using XhoI and KpnI restriction enzyme sites constructing pLN101.
The shcA deletion mutation carried on pLN101 was transferred to pHIR11 using a strategy based on the principle that ColE1 plasmids, such as pBluescript-II, cannot replicate in polA E. coli mutants, whereas broad-host-range plasmids, such as pHIR11, can. The procedure used has been described previously . Briefly, pLN101 was electroporated into E. coli C2110(pHIR11), and transformants were plated on LM plates selecting for the markers of both plasmids. Ap R and Tc R transformants were grown at 30∞C in 5 ml of LM broth containing tetracycline for four consecutive days. Each day, a small amount of the grown-up culture was transferred to fresh LM broth containing tetracycline. Dilutions (1:1000) were plated on LM media, and Tc R colonies were picked onto media containing tetracycline with and without ampicillin. DNA was isolated from Ap S colonies, and a pHIR11 derivative with a shcA deletion, named pLN85, was identified using PCR. pLN85 was conjugated by triparental mating, first into E. coli MC4100 and from that strain into P. fluorescens 55 with either DH5a or HB101 carrying the helper plasmid pRK2013.
Preparation of protein samples, SDS-PAGE and immunoblot analysis
The protein samples were made as described previously (van Dijk et al., 1999) with some modification. Briefly, Pseudomonas spp. were grown overnight on King's B plates at 30∞C. Cells were washed and resuspended in hrp-inducing fructose minimal medium (Huynh et al., 1989) and grown at 22∞C in a refrigerated shaking incubator. For P. s. syringae 61 cultures, cells were adjusted to an initial OD 600 of 0.15 and grown to an OD 600 of 0.3. For P. fluorescens 55 cultures, the starting OD 600 was 0.3, and the cultures were grown to an OD 600 of 0.5. Cultures (80 ml) were separated into cell-bound and supernatant fractions by centrifugation at 4∞C. The cell pellets were resuspended in 4 ml of H 2 O. The total protein present in the cell-bound fraction was determined according to the method of Bradford (1976) . SDS-PAGE tracking buffer was added to a 100 ml aliquot of the cell-bound fraction for analysis with SDS-PAGE. To prepare the supernatant fractions, 40 ml of the crude supernatant fractions were recentrifuged at 4∞C, and the top 20 ml was transferred to a new tube, and proteins were precipitated by adding trichloroacetic acid to 9.4% with incubation at 4∞C for 3 h. The protein pellets were gently washed with 5 ml of acetone and resuspended in 200 ml of SDS-PAGE tracking buffer.
Approximately 100 mg of total protein from each cell-bound fraction was added to SDS-PAGE gels. Based on the amount of protein in each cell-bound fraction, the amount of supernatant fraction loaded onto SDS-PAGE gels was adjusted to reflect total protein present in each culture. Proteins were separated with SDS-PAGE by standard procedures (Sambrook et al., 1989) , transferred to polyvinylidene difluoride membranes and immunoblotted using anti-HopPsyA, -HrpZ, -b-lactamase or -FLAG as primary antibodies. The production of anti-HopPsyA and -HrpZ antibodies was described previously (He et al., 1993; van Dijk et al., 1999) . The anti-b-lactamase antibodies were purchased from 5 Prime AE 3 Prime, and the anti-FLAG antibodies were purchased from Sigma Chemical. Primary antibodies were recognized by goat anti-rabbit immunoglobulin G-alkaline phosphatase conjugate (Sigma Chemical), which were visualized by chemiluminescence using a Western light chemiluminescence detection system (Tropix) and X-Omat X-ray film (Eastman Kodak).
The P. syringae ShcA type III chaperone 1479
Assay to determine ShcA-HopPsyA interaction
Samples of 100 ml of P. s. syringae UNL131 cultures were inoculated at a 1:100 dilution with fresh overnight cultures in King's B broth and grown to an OD 600 of 1.0. Cultures were centrifuged at 4∞C, resuspended in 5 ml of TBS (50 mM TrisHCl, 150 mM NaCl, pH 7.4), centrifuged again and cell pellets were stored at -80∞C. Cell pellets were resuspended in 10 ml of cold extraction buffer (50 mM Tris-HCl, 5 mM EDTA, pH 8.0) containing 1 mg ml -1 lysozyme and 0.5 mM phenylmethylsulphonyl fluoride (PMSF) and incubated on ice for 10 min. Cells were sonicated three times for 30 s, 1 ml of a high-salt buffer (1.5 M NaCl, 100 mM CaCl 2 , 100 mM MgCl 2 ) was added, and the cell lysates were centrifuged at 1200 r.p.m. at 4∞C. The aqueous phase was transferred to a new tube, and aliquots were saved separately for later analysis.
A sample of 120 ml of anti-FLAG gel, prepared according to the manufacturer's (Sigma Chemical) instructions, was mixed with 1.8 ml of each sonicate fraction and allowed to mix on a rotating shaker for 2 h at 4∞C. The anti-FLAG gel mixtures were centrifuged at low speeds and washed four times with 250 ml of TBS buffer. The last wash was saved for SDS-PAGE analysis. The washed anti-FLAG gel was resuspended in 50 ml of TBS, mixed with SDS-PAGE sample buffer and subjected to SDS-PAGE and immunoblot analysis as described above.
